[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100585855":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":25,"locations":35,"responsibleParty":52,"collaborators":54,"id":60,"slug":29,"hasResults":61,"nctId":62,"briefTitle":63,"officialTitle":63,"acronym":29,"eligibilityCriteria":64,"healthyVolunteers":61,"sex":65,"minAge":66,"maxAge":29,"enrollmentInfo":67,"targetDuration":29,"studyType":70,"phases":71,"briefSummary":73,"conditions":74,"keywords":77,"overallStatus":37,"whyStopped":29,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},{"fullName":5,"class":6},"Dana-Farber Cancer Institute","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"TRIAL Web-Based Application","EXPERIMENTAL","Enrolled participants will complete:\n\n* Baseline visit and questionnaires\n* Access to web application over the course of 14 days.\n* End of study questionnaires\n* 12 participants will take part in semi-structured interviews with study staff which will be audio recorded.",[13],"Behavioral: TRIAL Web-Based Application",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":19},"BEHAVIORAL","A web-based application that provides disease and trial education and access to resources provided by the Leukemia and Lymphoma Society (LLS). iPads will be provided to participants for 14 days.",[9],[20],"TRIAL",[22],{"name":23,"affiliation":5,"role":24},"Andrew Hantel, MD","PRINCIPAL_INVESTIGATOR",[26,31],{"name":23,"role":27,"phone":28,"phoneExt":29,"email":30},"CONTACT","617-582-9394",null,"Andrew_hantel@dfci.harvard.edu",{"name":32,"role":27,"phone":33,"phoneExt":29,"email":34},"Erin Gallagher","857-215-2275","erin_gallagher@dfci.harvard.edu",[36],{"facility":5,"status":37,"city":38,"state":39,"zip":40,"country":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"RECRUITING","Boston","Massachusetts","02215","United States",{"type":43,"coordinates":44},"Point",[45,46],-71.05977,42.35843,{"lat":46,"lon":45},[49,51],{"name":23,"role":27,"phone":28,"phoneExt":29,"email":50},"Andrew_Hantel@dfci.harvard.edu",{"name":23,"role":24,"phone":29,"phoneExt":29,"email":29},{"type":24,"investigatorFullName":23,"investigatorTitle":53,"investigatorAffiliation":5,"oldNameTitle":29,"oldOrganization":29},"Principal Investigator",[55,57],{"name":56,"class":6},"American Society of Clinical Oncology",{"name":58,"class":59},"National Cancer Institute (NCI)","NIH","100585855",false,"NCT06907797","Tools for Reducing Inequity in Acute Leukemia (TRIAL): Beta Testing","Inclusion Criteria:\n\n* Age 18 or older\n* English speaking\n* Ability to understand and willingness to sign written informed consent\n* Clinical suspicion of acute leukemia\n* Admitted to DFCI-affiliated inpatient unit\n\nExclusion Criteria:\n\n* Cognitive impairment rendering the individual unable to participate in beta testing\n\n  * This will be assessed by focused chart review and consultation with the patients' inpatient care team.\n* The following populations will be excluded: adults unable to consent, individuals who are not yet adults (infants, children, teenagers \\\u003C18 years old), prisoners.\n* Inability to participate in in-person application testing.\n* Patients who participated in alpha-testing through protocol 23-404 (Appendix A)","ALL","18 Years",{"count":68,"type":69},75,"ESTIMATED","INTERVENTIONAL",[72],"NA","This study aims to test the Tools for Reducing Inequity in Acute Leukemia (TRIAL) web-based application that is designed to support participants with acute leukemia by providing information and resources about leukemia and clinical trial participation.",[75,76],"Acute Leukemia","Leukemia",[75,76],"2026-05-18",{"date":80,"type":81},"2026-05-20","ACTUAL",{"date":83,"type":81},"2025-04-01",{"date":85,"type":69},"2027-06-30",{"name":5,"class":6},1]